Physician profile
Mark Bocado
NPI 1164929881
$2,814.84
in general payments reported to CMS, 2019-2025
18 companies · $694 in 2025
The $694 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $292 · 2022: $282 · 2023: $746 · 2024: $801 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,240.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $471.88 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $471.31 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $405.36 | 2021-2025 | Emblem Mri S-Icd, Acuity Steerable, Mylux Patient Kit With Mobile Device |
| Medtronic, INC. | $402.51 | 2022-2025 | Corevalve Evolut R, Linq II |
| Novartis Pharmaceuticals Corporation | $387.09 | 2021-2025 | |
| Edwards Lifesciences Corporation | $123.01 | 2021-2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $120.74 | 2023-2024 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $67.12 | 2021-2025 | Farxiga |
| Cvrx, INC. | $67.03 | 2023-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $59.49 | 2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $55.32 | 2024 | |
| Impulse Dynamics (USA) INC. | $35.32 | 2023 | Optimizer |
| Ge Healthcare | $31.20 | 2022-2023 | |
| Cardiva Medical, INC. | $31.17 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Scpharmaceuticals INC. | $27.77 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $23.73 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.93 | 2025 | |
| Kestra Medical Technology Services, INC. | $15.86 | 2024 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bocado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.